Polymer-based nanomedicines: Supporting multimodal approaches to glioblastoma multiforme treatment

Polymer-based nanomedicines may offer innovative strategies to enhance treatment for glioblastoma multiforme (GBM).

• GBM presents significant challenges for diagnosis and treatment due to factors like the blood-brain barrier and tumor heterogeneity.
• Recent studies indicate that polymers and polypeptides could facilitate better penetration of the blood-brain barrier and tumor accumulation.
• The combination of chemotherapeutic agents with molecularly targeted treatments using polymers may enhance therapeutic effects.
• Multimodal therapies incorporating distinct treatment methods, such as phototherapy and immunotherapy, could be supported by polymer-based platforms.
• Preclinical validation of these polymer-based approaches shows promise in complex models, indicating potential for improved GBM therapies.

AI simplified